title: Hemoglobin AC retinopathy managed with vitrectomy and adjunctive bevacizumab.
authors.forename: R
authors.initials: R
authors.lastname: Pokroy
authors.forename: U R
authors.initials: UR
authors.lastname: Desai
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D006455:Hemoglobins, Abnormal; D006801:Humans; D008297:Male; D012166:Retinal Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D015861:Retinal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D006455:Hemoglobins, Abnormal; D000068258:Bevacizumab; C076696:hemoglobin AC